HLA-B*5701 and abacavir hypersensitivity

被引：7
|
作者：
Watson, ME [1 ]
Pimenta, JM
Spreen, WR
Hernandez, JE
机构：
[1] GlaxoSmithKline, Res & Dev, Dept Global Hlth Outcomes, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
[2] GlaxoSmithKline, Res & Dev, Dept Epidemiol, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
[3] GlaxoSmithKline, Res & Dev, Dept Clin Dev, Infect Dis Med Dev Ctr HIV, Res Triangle Pk, NC USA
来源：
PHARMACOGENETICS | 2004年 / 14卷 / 11期
关键词：
D O I：
10.1097/00008571-200411000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [1] HLA-B*5701 screening for hypersensitivity to abacavir
    Mallal, Simon
    Phillips, Elizabeth
    Carosi, Giampiero
    Molina, Jean-Michel
    Workman, Cassy
    Tomazic, Janez
    Jaegel-Guedes, Eva
    Rugina, Sorin
    Kozyrev, Oleg
    Cid, Juan Flores
    Hay, Phillip
    Nolan, David
    Hughes, Sara
    Hughes, Arlene
    Ryan, Susanna
    Fitch, Nicholas
    Thorborn, Daren
    Benbow, Alastair
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 568 - 579
  • [2] HLA-B*5701 and abacavir hypersensitivity - Reply
    Hughes, D
    Park, BK
    Pirmohamed, M
    PHARMACOGENETICS, 2004, 14 (11): : 784 - 784
  • [3] HLA-B*5701 screening for hypersensitivity to abacavir
    Faruki, Hawazin
    Lai-Goldman, Myla
    PERSONALIZED MEDICINE, 2008, 5 (03) : 297 - 300
  • [4] HLA-B*5701 screening for susceptibility to abacavir hypersensitivity
    Lucas, Andrew
    Nolan, David
    Mallal, Simon
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 591 - 593
  • [5] The crystal structure of HLA-B*5701: Implications for abacavir hypersensitivity
    Archbold, JK
    Macdonald, WA
    Purcell, AW
    Chessman, D
    McCluskey, J
    Rossjohn, J
    TISSUE ANTIGENS, 2005, 66 (05): : 351 - 352
  • [6] HLA-B*5701 in HIV infected patients: relevance for abacavir hypersensitivity
    Athanassiades, Theophilos
    Kitsiou, Vassiliki
    Kouniaki, Diamando
    Magafas, Nikos
    Chini, Maria
    Lazanas, Marios
    Papasteriades, Chryssa
    TISSUE ANTIGENS, 2010, 75 (05): : 640 - 640
  • [7] Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions
    Reeves, I.
    Churchill, D.
    Fisher, M.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L11 - L11
  • [8] Association of HLA-B*5701 and hypersensitivity to abacavir in a sample of Thai patients
    Bowonwatanuwong, C
    Warren, L
    Mosteller, M
    Haneline, S
    Handley, A
    Champreeda, P
    Brothers, C
    Spreen, W
    Hughes, A
    Hernandez, J
    ANTIVIRAL THERAPY, 2005, 10 (08) : L61 - L61
  • [9] Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards
    Rodriguez-Novoa, Sonia
    Garcia-Gasco, Pilar
    Blanco, Francisco
    Gonzalez-Pardo, Gema
    Castellares, Carol
    Moreno, Victoria
    Jimenez-Nacher, Inmaculada
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (11) : 1374 - 1376
  • [10] HLA-B*5701 screening for abacavir hypersensitivity: experience of a UK centre
    Hopkins, K. L.
    Gompels, M. M.
    Lock, R. J.
    Johnston, S. L.
    Ward, J. J.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (06) : 499 - 499
12345